|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1102 - 0.1102|
|52 Week Range||0.0630 - 0.7050|
|Beta (3Y Monthly)||1.70|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
GLASGOW, SCOTLAND, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc has been advised of a significant increase in the share price and trading volume of the Company's shares beginning Monday February 25, 2019. The Company has been advised by OTC Markets Group that the Company is the subject of a promotional campaign by newsletter writers. The material being distributed contains promotional language pertaining to the Company's business, activities and future share price.
GLASGOW, SCOTLAND, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. ("the Company" (OTCQB: VICA)) is pleased to announce that it has developed a product prototype to assist patients with Deep Vein Thrombosis. Deep Vein Thrombosis (“DVT”) occurs when blood clots form inside veins deep inside the body. Constantinos Zertalis, Rafina’s Chairman, President and CEO, commented: "I am very excited to have this operational prototype ready for the next steps, including discussions with third parties for possible commercialization.
NEW YORK, NY / ACCESSWIRE / February 25, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Rafina Innovations Inc. (VICA). Rafina Innovations operates two wholly owned subsidiaries in Glasgow UK. Recent changes to Rafina share structure, Insider buying and more in this full report READ MORE.
Constantinos Zertalis, Rafina’s Chairman, President and CEO, commented: "Our research shows that 1 in 6 people suffer from respiratory failure that requires a biPAP machine. Following investigation into the marketspace and needs of the consumer, our research and development team believe we can produce biPAP equipment that can be small in size, travel friendly and also energy efficient.
Glasgow, Scotland, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. (formerly HCi Viocare) (VICA), provides update on recent management changes. Rafina Innovations Inc. was created to be a dynamic technology start-up. Mr. Constantinos Zertalis has been appointed President and CEO of Rafina Innovations Inc. As we shift from company-creation to company-growth, Mr. Zertalis will provide the leadership the company needs for its next phase.